Otros idiomas Evolent Health, Inc.

Acciones

EVH

US30050B1017

Mercado cerrado - Nyse Otros sitios de cotización 22:00:02 22/05/2024			Varia. Cinco días.	Varia. 1 de enero.
23,27 ^USD	+1,26 %		-1,19 %	-29,55 %

14/05	EVOLENT HEALTH, INC. : Truist Securities se mantiene neutral sin recomendación.	ZM
10/05	EVOLENT HEALTH, INC. : UBS reitera su recomendación de compra	ZM

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Evolent Health: Q1 Earnings Snapshot	09/05
Evolent Health Q1 Adjusted Earnings, Revenue Rise; Q2 Revenue Guidance Set, 2024 Revenue Outlook Increased	09/05
Earnings Flash (EVH) EVOLENT HEALTH Posts Q1 EPS $0.34, vs. Street Est of $0.30	09/05
Earnings Flash (EVH) EVOLENT HEALTH Posts Q1 Revenue $639.7M, vs. Street Est of $598.9M	09/05
Evolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.	09/05
Evolent Health, Inc. and Careology Form Strategic Care Navigation Partnership to Enhance Cancer Care in the U.S	09/05
Evolent Announces First Quarter 2024 Results	09/05
Evolent Health, Inc. Provides Earnings Guidance for the Second Quarter Ending June 30, 2024 and Raises Earnings Guidance for the Full Year Full Year Ending December 31, 2024	09/05
Evolent Health : 2024 Notice of Meeting and Proxy Statement	26/04
Evolent Health : 2024 Proxy Card	26/04
Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024	18/04
Evolent Health Q4 Adjusted Income, Revenue Rise; Q1, 2024 Revenue Guidance Set; Shares Jump After Hours	22/02
Evolent Health: Q4 Earnings Snapshot	22/02
Earnings Flash (EVH) EVOLENT HEALTH Reports Q4 EPS $0.23, vs. Street Est of $0.15	22/02
Earnings Flash (EVH) EVOLENT HEALTH Posts Q4 Revenue $556.1M, vs. Street Est of $542.9M	22/02
Evolent Announces Fourth Quarter and Full Year 2023 Results	22/02
Evolent Health, Inc. Provides Earnings Guidance for the First Quarter Ending March 31, 2024 and Full Year Ending December 31, 2024	22/02
Evolent Health, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	22/02
Evolent Adds Russell Glass, Headspace CEO, to Board of Directors	14/02
Evolent Health, Inc. Announces Board Changes	14/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Evolent Health, Inc.

Acciones

EVH

US30050B1017

Otros idiomas

Filtros